Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600976 stock hub

SHA/600976 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600976is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600976

In the news

Latest news · SHA/600976

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E14.7

P25 23.5P50 41.3P75 83.2

ROE12.9

P25 -0.9P50 4.1P75 8.8

ROIC12.2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600976 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,257
Employees Change	-88%
Employees Change Percent	-3.75
Enterprise value	CNY 4B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001HB7
Last refreshed	2026-05-10
Market cap	CNY 5B
Price	CNY 32.44
Price currency	CNY
Rev Per Employee	1,484,668.13x
Sector	Healthcare
Sic	2834
Symbol	sha/600976
Website	https://www.whjm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.78%
EV Earnings	11.75x
EV/EBIT	18.3x
EV/EBITDA	15.11x
EV/FCF	16.7x
EV/Sales	1.18x
FCF yield	4.77%
P/B ratio	1.8x
P/E ratio	14.75x
P/S ratio	1.49x
PE Ratio10 Y	30.66x
PE Ratio3 Y	18.01x
PE Ratio5 Y	21.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.46%
EBITDA Margin	7.6%
FCF margin	7.08%
Gross margin	60.16%
Gross Profit	CNY 2B
Gross Profit Growth	13.81%
Gross Profit Growth Q	10.77%
Gross Profit Growth3 Y	6.21%
Gross Profit Growth5 Y	11.01%
Net Income	CNY 337.4M
Net Income Growth	-9.5%
Net Income Growth Q	-20.37%
Net Income Growth Years	0%
Net Income Growth3 Y	-6.96%
Net Income Growth5 Y	11.1%
Pretax Margin	10.86%
Profit Margin	10.07%
Profit Per Employee	CNY 149,489
Profitable Years	25
ROA	3.02
Roa5y	4.02
ROCE	7.52
ROE	12.86
Roe5y	20.25
ROIC	12.24
Roic5y	19.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.64%
Cagr15y	5.08%
Cagr1y	-20.73%
Cagr20y	10.5%
Cagr3y	-19.14%
Cagr5y	1.1%
Div CAGR10	16.23%
Div CAGR3	-3.45%
Div CAGR5	19.72%
EPS Growth	-10.55
EPS Growth Q	-21.65
EPS Growth Years	0
EPS Growth3 Y	-7.18
EPS Growth5 Y	11.02
FCF Growth	73.02%
FCF Growth3 Y	6.61%
FCF Growth5 Y	13.34%
OCF Growth	32.29%
OCF Growth10 Y	71.31%
OCF Growth3 Y	8.56%
OCF Growth5 Y	14.55%
Revenue Growth	-2.22x
Revenue Growth Q	-2.13x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.56x
Revenue Growth5 Y	3.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.75
Assets	CNY 4.7B
Cash	CNY 1.1B
Current Assets	CNY 2.8B
Current Liabilities	CNY 1.8B
Debt	CNY 95.5M
Debt EBITDA	CNY 0.36
Debt Equity	CNY 0.03
Debt FCF	CNY 0.4
Equity	CNY 2.8B
Interest Coverage	17.21
Liabilities	CNY 1.9B
Long Term Assets	CNY 1.9B
Long Term Liabilities	CNY 115.7M
Net Cash	CNY 1B
Net Cash By Market Cap	CNY 20.75
Net Cash Growth	-1.69%
Net Debt EBITDA	CNY -4.05
Net Debt Equity	CNY -0.37
Net Debt FCF	CNY -4.35
Tangible Book Value	CNY 2.7B
Tangible Book Value Per Share	CNY 17.71
WACC	5.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	4.21
Net Working Capital	CNY -114.3M
Quick ratio	1.28
Working Capital	CNY 987.1M
Working Capital Turnover	CNY 3.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.17%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.9
Dividend Years	18
Dividend Yield	2.77%
Ex Div Date	2026-04-28
Last Dividend	CNY 0.9
Payout Frequency	Annual
Payout Ratio	41.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	42.99%
1Y total return	-20.72%
200-day SMA	37.13
3Y total return	-47.13%
50-day SMA	32.78
50-day SMA vs 200-day SMA	50under200
5Y total return	5.63%
All Time High	86.78
All Time High Change	-62.62%
All Time High Date	2022-01-04
All Time Low	3.73
All Time Low Change	770.87%
All Time Low Date	2005-05-10
ATR	0.81
Beta	0.2
Beta1y	-0.08
Beta2y	0.02
Ch YTD	-3.37
High	32.72
High52	43.72
High52 Date	2025-09-11
High52ch	-25.8%
Low	32.15
Low52	31.03
Low52 Date	2026-03-04
Low52ch	4.54%
Ma50ch	-1.03%
Price vs 200-day SMA	-12.62%
RSI	45.72
RSI Monthly	38.16
RSI Weekly	37.17
Sharpe ratio	-1.85x
Sortino ratio	-2.24
Total Return	1.61%
Tr YTD	-0.67
Tr15y	110.17%
Tr1m	-3.07%
Tr1w	2.46%
Tr3m	-3.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 216.6M
Operating Income Growth	43.33
Operating Income Growth Q	-9.71
Operating Income Growth3 Y	-6.93
Operating Income Growth5 Y	21.58
Operating margin	6.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	108,736,929%
Net Borrowing	-71,533,848
Shares Insiders	0.8%
Shares Institutions	19.81%
Shares Out	153,398,600
Shares Qo Q	1.34%
Shares Yo Y	1.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 237.4M
Average Volume	2,218,832.5x
Bv Per Share	17.89
CAPEX	CNY -107.9M
Ch10y	22.37
Ch15y	64
Ch1m	-5.7
Ch1w	2.46
Ch1y	-22.87
Ch20y	466.1
Ch3m	-5.97
Ch3y	-51.46
Ch5y	-5.67
Ch6m	-16.61
Change	0.62%
Change From Open	-0.64
Close	32.24
Days Gap	1.27
Depreciation Amortization	38,221,975
Dollar Volume	59,186,780
Earnings Date	2026-03-21
EBIT	CNY 216.6M
EBITDA	CNY 254.8M
EPS	CNY 2.2
F Score	5
FCF	CNY 237.4M
FCF EV Yield	5.99x
FCF Per Share	CNY 1.55
Financing CF	-215,075,846
Fiscal Year End	December
Founded	1,637
Goodwill	214,035
Graham Number	29.75378
Graham Upside	-8.28
Income Tax	CNY 21.3M
Investing CF	-237,223,366
Is Primary Listing	1
Last Earnings Date	2026-03-21
Last Report Date	2026-03-31
Last Split Date	2006-07-12
Last Split Type	Forward
Lynch Fair Value	CNY 24.42
Lynch Upside	-24.73
Ma150	35.7
Ma150ch	-9.13%
Ma20	33.06
Ma20ch	-1.86%
Net CF	-107,028,199
Open	32.65
P FCF Ratio	20.96
P OCF Ratio	14.41
Payment Date	2026-04-28
Position In Range	50.88
Ppne	690,720,554
Price Date	2026-05-08
Price EBITDA	CNY 19.53
Ptbv Ratio	1.83
Relative Volume	0.83x
Revenue	3,350,895,967x
Tax By Revenue	0.64x
Tax Rate	5.86%
Tr20y	635.96%
Tr6m	-14.28%
Volume	1,824,500
Z Score	3.59

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600976 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$0.90 annual per share

Payout ratio

+41.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+19.7%

0 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2026-04-28

Performance

SHA/600976 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600976?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.8%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.2%

Negative means the company is buying back shares.

Technical

SHA/600976 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.7

Neutral momentum band

Price vs 200-day MA

-12.6%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

-1.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600976

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600976 stock rating?

sha/600976 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600976 analysis?

The full report lives at /stocks/sha/600976/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600976?

The latest report frames sha/600976 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600976 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.